---
title: "Sotalol - Atrial fibrillation"
sidebar: mydoc_sidebar
permalink: sotalolatrialfibrillation2.html
toc: false 
---

{% include image.html file="sotalolatrialfibrillation2.png" alt="sotalolatrialfibrillation2" %}![Path Visualization](/images/sotalolatrialfibrillation2.png)

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D013015 | Sotalol | Drug |
| UniProt:Q12809 | Potassium voltage-gated channel subfamily H member 2 | Protein |
| GO:0086009 | repolarization | BiologicalProcess |
| GO:0060047 | relaxation of the ventricles | BiologicalProcess |
| GO:0015276 | ionotropic effect | BiologicalProcess |
| MESH:D001281 | Atrial fibrillation | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Sotalol | DECREASES ACTIVITY OF | Potassium Voltage-Gated Channel Subfamily H Member 2 |
| Potassium Voltage-Gated Channel Subfamily H Member 2 | NEGATIVELY REGULATES | Repolarization |
| Repolarization | AFFECTS ACTIVITY OF | Relaxation Of The Ventricles |
| Relaxation Of The Ventricles | NEGATIVELY REGULATES | Ionotropic Effect |
| Ionotropic Effect | CAUSED BY | Atrial Fibrillation |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB:DB00489#mechanism-of-action](https://go.drugbank.com/drugs/DB:DB00489#mechanism-of-action){:target="_blank"}